EXACT SCIENCES CORP (38)

Browse by Contract Category

Contracts

Second Amendment to Agreement and Plan of Merger dated January 4, 2021 (Filed With SEC on January 5, 2021)
Second Amended and Restated License Agreement, effective January 31, 2020, by and between Mayo Foundation for Medical Education and Research and the Registrant (Filed With SEC on October 27, 2020)
Amended & Restated Cologuard Promotion Agreement by and between Exact Sciences Corporation and Pfizer Inc. dated October 6, 2020 (Filed With SEC on October 7, 2020)
The Registrants Non-Employee Director Compensation Policy, dated April 21, 2020 (Filed With SEC on July 31, 2020)
Amendment No. 1 to Construction Loan Agreement and Construction Note, dated June 30, 2020, by and between Fifth Third Bank, National Association and CG Growth LLC (Filed With SEC on July 31, 2020)
Lease Agreement, dated September 23, 2005, by and between Metropolitan Life Insurance Company and Genomic Health, Inc (Filed With SEC on February 21, 2020)
First Amendment to Agreement and Plan of Merger dated December 23, 2020 (Filed With SEC on January 5, 2021)
Agreement and Plan of Merger, dated as of October 26, 2020, by and among Exact Sciences Corporation, Eagle Merger Sub I, Inc., Eagle Merger Sub II, LLC, Thrive Earlier Detection... (Filed With SEC on October 27, 2020)
Employment Agreement, dated as of April 20, 2020, by and between Gisela Paulsen and the Registrant (Filed With SEC on July 31, 2020)
The Registrants Non-Employee Director Compensation Policy, dated January 28, 2020 (Filed With SEC on May 6, 2020)
Severance and Release of Claims Agreement, dated as of February 3, 2020, by and between G. Bradley Cole and Genomic Health, Inc (Filed With SEC on May 6, 2020)
Non-Employee Director Compensation Policy dated April 22, 2020 (Filed With SEC on April 24, 2020)
Third Supplemental Indenture, dated February 27, 2020, between the Company and U.S. Bank National Association, as Trustee (including the form of 0.3750% Convertible Senior Notes... (Filed With SEC on February 27, 2020)
Underwriting Agreement, dated February 24, 2020, by and between the Company and BofA Securities, Inc., as representative of the several underwriters named therein (Filed With SEC on February 27, 2020)
The Registrant's 2019 Omnibus Long-Term Incentive Plan Form Stock Option Award Agreement (Filed With SEC on February 21, 2020)
Lease Agreement, dated November 11, 2015, by and between Metropolitan Life Insurance Company and Genomic Health, Inc (Filed With SEC on February 21, 2020)
The Registrant's 2019 Omnibus Long-Term Incentive Plan Form Restricted Stock Award Agreement (Filed With SEC on February 21, 2020)
The Registrant's 2019 Omnibus Long-Term Incentive Plan Form Restricted Stock Unit Award Agreement (Filed With SEC on February 21, 2020)
Employment Agreement, dated February 18, 2019, by and between Jacob Orville and the Registrant (Filed With SEC on February 21, 2020)
Employment Agreement, dated September 1, 2017, by and between Torsten Hoof and Genomic Health International Srl (Filed With SEC on February 21, 2020)
First Amendment to Lease Agreement, dated October 4, 2019, by and between Metropolitan Life Insurance Company and Genomic Health, Inc (Filed With SEC on February 21, 2020)
First Amendment to Lease Agreement, dated September 5, 2006, by and between Metropolitan Life Insurance Company and Genomic Health, Inc (Filed With SEC on February 21, 2020)
Third Amendment to Lease Agreement, dated November 11, 2015, by and between Metropolitan Life Insurance Company and Genomic Health, Inc (Filed With SEC on February 21, 2020)
Fourth Amendment to Lease Agreement, dated October 4, 2019, by and between Metropolitan Life Insurance Company and Genomic Health, Inc (Filed With SEC on February 21, 2020)
Second Amendment to Lease Agreement, dated November 30, 2010, by and between Metropolitan Life Insurance Company and Genomic Health, Inc (Filed With SEC on February 21, 2020)
First Amendment to Employment Agreement, dated September 11, 2017, by and between Torsten Hoof and Genomic Health International Srl (Filed With SEC on February 21, 2020)
Second Amendment to Employment Agreement, dated November 13, 2020, by and between Torsten Hoof and Genomic Health International Srl (Filed With SEC on February 21, 2020)
Retention Bonus and Retention Equity Letter Agreement, dated as of November 15, 2020, by and between G. Brad Cole and the Registrant (Filed With SEC on February 21, 2020)
Agreement and Plan of Merger, dated as of July 28, 2019, by and among Exact Sciences Corporation, Spring Acquisition Corp. and Genomic Health, Inc (Filed With SEC on July 30, 2019)
Amendment No. 3 to Exact Sciences Corporation 2010 Employee Stock Purchase Plan (Filed With SEC on July 30, 2019)
Second Supplemental Indenture, dated March 8, 2019, between the Company and U.S. Bank National Association, as Trustee (including the form of 0.3750% Convertible Senior Notes due... (Filed With SEC on March 8, 2019)
Underwriting Agreement, dated March 5, 2019, by and between the Company and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as representative of the several underwriters named... (Filed With SEC on March 8, 2019)
The Registrants Non-Employee Director Compensation Policy dated January 29, 2019 (Filed With SEC on February 21, 2019)
Employment Agreement dated September 11, 2017 by and between Scott Johnson and the Registrant (Filed With SEC on February 21, 2019)
Third Amendment dated effective October 1, 2017 to Amended and Restated License Agreement dated effective January 1, 2019, by and among the Registrant, Mayo Foundation for Medical... (Filed With SEC on February 21, 2019)
The Registrants Executive Deferred Compensation Plan dated January 1, 2019 (Filed With SEC on February 21, 2019)
The Registrants Non-Employee Director Compensation Policy dated October 25, 2018 (Filed With SEC on February 21, 2019)
Second Amended and Restated Lease Agreement, dated September 28, 2018, by and between University Research Park Incorporated and the Registrant (Filed With SEC on February 21, 2019)